Next generation Point-of-care diagnostics for Dengue, Zika and infectious diseases
BluSense Diagnostics on Twitter: "Visit BluSense Diagnostics at Booth F36 in Hall 16 at #MEDICA2021 in 🇩🇪! The BluBox is able to provide you with an accurate quantitative #COVID19 Total Antibody profile
Blusense Diagnostics - Fra doktorgrad til effektive diagnoser - Symbion
BluSense Diagnostics - A journey from dream to medical device sold around the world in just 4 years
EPO - Donolato
BluSense Diagnostics | Copenhagen
BluSense Diagnostics adopts PI's NeoSync to remotely monitor and manage its fleet of point-of-care diagnostic instruments - Planet Innovation
Fast and reliable diagnostics tests - KPMG Denmark
Diagnostics | Free Full-Text | Evaluation of ViroTrack Sero Zika IgG/IgM, a New Rapid and Quantitative Zika Serological Diagnostic Assay
Biosensors | Free Full-Text | Evaluation of the Diagnostic Accuracy of a New Biosensors-Based Rapid Diagnostic Test for the Point-Of-Care Diagnosis of Previous and Recent Dengue Infections in Malaysia
Virus Outbreak: Taiwanese-Danish firm develops testing device - Taipei Times
BluSense Diagnostics | LinkedIn
BluSense Diagnostics: Towards a new zika cure - Symbion
Marco Donolato and Team, finalists for the European Inventor Award 2021 | CIC nanoGUNE
Diagnostikselskab fyrer topchef efter skuffende 2022 — MedWatch
Filippo Bosco | EIT Awards 2020
BlueSense Diagnostics ApS - company profile & statistics
Spin-out recognised with Good Design Award for blood testing device - Med-Tech Innovation
BluSense Diagnostics – BluSense – Driven by visionaries powered by scientists
Combating Zika - Award Nominees | Combating Zika and Future Threats: A Grand Challenge for Development | Archive - U.S. Agency for International Development
